Johnson & Johnson (JNJ) Sees FY13 Revs at $70.4B - $71.1B; Est. at $71.1B
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $262.32 +3.28%
Revenue Growth %: +5.1%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
PKE, LNN, More
Revenue Growth %: +5.1%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) sees FY13 sales of $70.4 billion to $71.1 billion. The Street is currently at about $71.1 billion.
Earlier, the
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
Earlier, the
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Q2 deliveries reach 480,126, topping estimates of 406,024
- Biogen expects $164M R&D charge to hit Q2 2026 earnings
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
